Enhancement of lymphocyte function and interleukin 1β transcription by recombinant bovine interleukin 1β

Judith R. Stabel From the USDA, Agricultural Research Service, National Animal Disease Center, Mycobacteriology Research Unit (Stabel), Metabolic Diseases and Immunology Research Unit (Kehrli, Goff), PO Box 70, Ames, IA 50010.

Search for other papers by Judith R. Stabel in
Current site
Google Scholar
PubMed
Close
 PhD
,
Marcus E. Kehrli Jr. From the USDA, Agricultural Research Service, National Animal Disease Center, Mycobacteriology Research Unit (Stabel), Metabolic Diseases and Immunology Research Unit (Kehrli, Goff), PO Box 70, Ames, IA 50010.

Search for other papers by Marcus E. Kehrli Jr. in
Current site
Google Scholar
PubMed
Close
 DVM, PhD
, and
Jesse P. Goff From the USDA, Agricultural Research Service, National Animal Disease Center, Mycobacteriology Research Unit (Stabel), Metabolic Diseases and Immunology Research Unit (Kehrli, Goff), PO Box 70, Ames, IA 50010.

Search for other papers by Jesse P. Goff in
Current site
Google Scholar
PubMed
Close
 DVM, PhD

SUMMARY

Six nonpregnant, nonlactating Jersey cows, averaging 4 to 6 years old, were used to evaluate the immunomodulatory effects of recombinant bovine interleukin 1β (rBoIL-1β). Cows were given 166 ng of rBoIL-1β/kg of body weight at 8-hour intervals for 96 hours. Persistent leukocytosis was observed within 3 hours of rBoIL-1 treatment, peaking 24 hours after the first IL-1β injection and returning to baseline values within 72 hours after cessation of IL-1β treatment. Injection of cows with rBoIL-1β stimulated lymphocyte blastogenesis and mitochondrial methyl-thiazoltetrazolium cleavage activity in resting cell cultures. Increases in the aforementioned lymphocyte activities were also observed in stimulated blood mononuclear cell cultures during IL-1β administration. Change in IgM production in cell cultures was not observed during IL-1β treatment. Within 24 hours of the first IL-1β injection, IL-1β mRNA transcription in stimulated blood mononuclear cell cultures was markedly increased, suggesting that IL-1β upregulates its own production in mononuclear cells. These data provide evidence that administration of cytokines, such as rBoIL-1β, enhances immune cell function and, therefore, may be useful in alleviating immunosuppression in cattle.

SUMMARY

Six nonpregnant, nonlactating Jersey cows, averaging 4 to 6 years old, were used to evaluate the immunomodulatory effects of recombinant bovine interleukin 1β (rBoIL-1β). Cows were given 166 ng of rBoIL-1β/kg of body weight at 8-hour intervals for 96 hours. Persistent leukocytosis was observed within 3 hours of rBoIL-1 treatment, peaking 24 hours after the first IL-1β injection and returning to baseline values within 72 hours after cessation of IL-1β treatment. Injection of cows with rBoIL-1β stimulated lymphocyte blastogenesis and mitochondrial methyl-thiazoltetrazolium cleavage activity in resting cell cultures. Increases in the aforementioned lymphocyte activities were also observed in stimulated blood mononuclear cell cultures during IL-1β administration. Change in IgM production in cell cultures was not observed during IL-1β treatment. Within 24 hours of the first IL-1β injection, IL-1β mRNA transcription in stimulated blood mononuclear cell cultures was markedly increased, suggesting that IL-1β upregulates its own production in mononuclear cells. These data provide evidence that administration of cytokines, such as rBoIL-1β, enhances immune cell function and, therefore, may be useful in alleviating immunosuppression in cattle.

Advertisement